Serpentine Supravenous Hyperpigmentation Following Intravenous Docetaxel
Serpentine supravenous hyperpigmentation is a rare, cutaneous sequela of intravenous chemotherapeutic agents, collagen vascular diseases (systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis), and infections like leprosy and HIV. The condition manifests clinically as a peculiar...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Pigment International |
| Subjects: | |
| Online Access: | http://www.pigmentinternational.com/article.asp?issn=2349-5847;year=2021;volume=8;issue=2;spage=109;epage=111;aulast=Mondal |
| Summary: | Serpentine supravenous hyperpigmentation is a rare, cutaneous sequela of intravenous chemotherapeutic agents, collagen vascular diseases (systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis), and infections like leprosy and HIV. The condition manifests clinically as a peculiar, patterned eruption characterized by hyperpigmented streaks following the superficial venous network on the skin. Here, we report a case of a middle-aged lady with breast carcinoma, who developed serpentine supravenous hyperpigmentation after intravenous docetaxel. |
|---|---|
| ISSN: | 2349-5847 2349-5782 |